Expertise in
5
conditions

Michael E. O'dwyer

Newcastle Road, 
Gaillimh, C, IE 
Expertise in
5
conditions
Newcastle Road, 
Gaillimh, C, IE 

Overview

Michael O'dwyer practices practicing medicine in Gaillimh, Ireland.

Mr. O'dwyer is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Leukemia, Cerebral Hypoxia, and Acute Myeloid Leukemia (AML).

He is actively involved in clinical research, co-authoring 92 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Newcastle Road, Gaillimh, C, Ireland
Other Locations
Newcastle Road, H91 YR71, Gaillimh, C, Ireland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Drug
Study Drug: Lenalidomide
Study Phase: Phase 3
A Phase III Randomized, Double-Blind Trial to Evaluate the Efficacy of Uproleselan Administered With Chemotherapy Versus Chemotherapy Alone in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A Phase III Randomized, Double-Blind Trial to Evaluate the Efficacy of Uproleselan Administered With Chemotherapy Versus Chemotherapy Alone in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Enrollment Status: Terminated
Publish Date: July 29, 2024
Intervention Type: Drug
Study Drug: Uproleselan
Study Phase: Phase 3
A Phase I Open-Label Dose Escalation Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care Chemotherapy for the Treatment of Multiple Myeloma
A Phase I Open-Label Dose Escalation Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care Chemotherapy for the Treatment of Multiple Myeloma
Enrollment Status: Completed
Publish Date: July 10, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Phase I/II, Open-label Multicenter Trial to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in Patients With Acute Myeloid Leukemia
A Phase I/II, Open-label Multicenter Trial to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in Patients With Acute Myeloid Leukemia
Enrollment Status: Completed
Publish Date: May 17, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Phase Ib Study of Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) in Transplant Eligible Patients With Newly Diagnosed Multiple Myeloma (MM): The CyBorD-DARA Study
Phase Ib Study of Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) in Transplant Eligible Patients With Newly Diagnosed Multiple Myeloma (MM): The CyBorD-DARA Study
Enrollment Status: Unknown
Publish Date: March 29, 2018
Intervention Type: Drug
Study Drugs: Daratumumab, Cyclophosphamide, Bortezomib, Dexamethasone
Study Phase: Phase 1
View 4 Less Clinical Trials

92 Total Publications

Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.
Journal: Human gene therapy
Published: August 03, 2026

Frequently Asked Questions about Michael E. O'dwyer

Is Michael E. O'dwyer a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Michael E. O'dwyer is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michael E. O'dwyer participate in research or clinical trials?

Yes. Michael E. O'dwyer has published 92 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Michael E. O'dwyer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. O'dwyer's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile